Setbacks, shortages undercutting Covid treatments; major lobbying win for pharmacies may be ahead

Supply of some of the treatments, particularly the prized new oral treatment Paxlovid, is extremely constrained. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by        Doctors have an arsenal of Covid-19 treatments, but setbacks and shortages are undercutting options By Andrew Joseph Pfizer Doctors have an arsenal of different Covid-19 treatments, but setbacks and shortages are undercutting the options. Read More STAT+: Biden administration poised to give pharmacies a major lobbying win By Rachel Cohrs and Ed Silverman Sergio Flores/Getty Images The Biden administration wants to rein in pharmacy fees charged by controversial drug middlemen in Medicare. Read More Supreme Court skeptical of Biden's workplace vaccine rule By Mark Sherman and Jessica Gresko — Associated Press Evan Vucci/AP The conservative majority appeared skeptical of the administration's authority to impose a vaccine-or-testing requirement on large employers. Read More Sponsor content by Amgen How does a molecule go from discovery to development? Getting a medicine from the lab into the hands of patients doesn't come easily, as David Reese, Executive Vice President, Research and Development at Amgen, will tell you. "It takes more than a village — it takes an army that has worked for many years. That's why we're here, it's why I come to work every day." Hear from David, scientists, and researchers about what it takes to bring a molecule from discovery to development. Opinion: Omicron magnifies the distress in the health care labor system By Harris Solomon JOSEPH PREZIOSO/AFP via Getty Images Health care workers in short-staffed ICUs need fair wages, policies that sustain safe workplaces, and not having their work taken for granted. Read More STAT+: What money? Pharma donations to patient groups in Canada are shrouded in mystery By Ed Silverman Adobe A new analysis finds there is transparency is lacking around pharma donations to patient advocacy groups in Canada. Read More Opinion: Out-of-pocket drug costs for Medicare beneficiaries need to be reined in By Reshma Ramachandran and Tianna Zhou and Joseph S. Ross Adobe For Medicare-covered seniors with chronic conditions, out-of-pocket costs for medications increased by more than 40% between 2009 and 2019. Read More Friday, January 7, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser